Cryo-Cell International (CCEL) is a cord blood and cord tissue banking company that collects, processes, and stores newborn stem cells for potential future medical use. The company makes money by charging families an upfront processing fee at the time of collection and recurring annual storage fees for the ongoing preservation of the biological material. The filing excerpts from the 10-K filed 2026-02-27 covering fiscal year ended November 30, 2025 identify the company as Cryo-Cell International, Inc. The business operates under a subscription-like storage model, where the recurring storage fee component provides a base of contractual, long-term revenue tied to the number of specimens under management. Switching costs are meaningful once a family has enrolled, as transferring stored biological samples is logistically complex and emotionally sensitive.
Source: SEC 10-K, filed 2026-02-27
Industry: Services-Misc Health & Allied Services, NEC Peers: AKUMIN INC. Biodesix Inc Bimergen Energy Corp CVS Health Corp ENZO BIOCHEM INC InfuSystem Holdings Inc Talkspace Inc WeCapital Holdings, Inc. Psychemedics Corp
Loading...